Telemedicine Management Services Agreements: Corporate Practice of Medicine, Fee-Splitting, Regulatory Compliance

Course Details
- smart_display Format
On-Demand
- signal_cellular_alt Difficulty Level
Intermediate
- work Practice Area
Health
- event Date
Wednesday, May 29, 2024
- schedule Time
1:00 p.m. ET./10:00 a.m. PT
- timer Program Length
90 minutes
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
This CLE course will guide healthcare counsel on structuring telemedicine management service agreements. The panel will discuss considerations for both the management group and the healthcare providers and the legal risks with such agreements. The panel will also discuss an IRS rule that addresses healthcare management services. The panel will offer best practices for addressing healthcare regulatory issues in telemedicine management services.
Faculty

Mr. Cohen practices in the firm’s nationally recognized Life Sciences practice. He counsels healthcare services, life sciences, and healthcare IT clients concerning compliance with the myriad laws and regulations governing the delivery of healthcare services such as the Anti-Kickback Statute, the Physician Self-Referral Law (the Stark Law), the False Claims Act, the Health Insurance Portability and Accountability Act of 1996 (HIPAA), Medicare and Medicaid rules and regulations, and laws governing reimbursement, licensure and certification. Mr. Cohen’s experience also includes extensive work on healthcare transactions, with deep experience assisting clients in transactions involving and providing counsel to health IT companies such as telemedicine providers and electronic health record, mobile health (mHealth), and digital health companies. In addition to his transactional work, Mr. Cohen has a long track record of successfully representing healthcare and life science clients in government investigations and litigation. Mr. Cohen is a Visiting Instructor at the Weill Cornell Graduate School of Medical Sciences where he teaches a class on healthcare law and is a frequent speaker at healthcare industry events and regularly publishes articles about healthcare law.

Widely recognized as a digital health thought leader, Mr. Sherer counsels health care providers and suppliers – including hospital systems, national telehealth platforms, investors and digital health startups – on issues involving regulatory compliance, transactions and innovative business arrangements. He advises clients on the full range of regulatory health care issues facing digital health stakeholders. His telehealth experience includes advising on compliance with state licensure requirements for physicians and non-physician practitioners, corporate practice of medicine issues, remote prescribing (including controlled substances), patient consent and Medicare, Medicaid and commercial reimbursement. Mr. Sher advises clients on compliance with laws against fraud and abuse, including federal and state anti-kickback and self-referral laws, as well as privacy issues arising under HIPAA and its state-level counterparts. He has substantial experience pertaining to structuring, operationalizing and scaling “PC-MSO” arrangements across all 50 states. Mr. Sherer also advises venture capital and private equity firms conducting regulatory diligence associated with investments in digital health and health care technology ventures, from seed stage funding to nine-figure raises.

Ms. de la Houssaye is Co-Leader of the firm's Healthcare Litigation Team and Chairs the Healthcare Industry Telemedicine Team. She works extensively with hospitals, health systems, providers, and start-up companies to structure and integrate telemedicine, telehealth, and digital health platforms. Ms. de la Houssaye has a broad-based litigation and healthcare regulatory practice advising clients from across the industry spectrum. Drawing on her more than 25 years in private practice and her firsthand experience as co-founder of and general counsel to one of Louisiana’s first teleradiology networks, she helps clients navigate the rapidly developing regulatory landscape affecting today’s healthcare delivery, including U.S. FDA application and registration processes and emergency use authorization approvals, U.S. Centers for Medicare & Medicaid Services coverage issues, state corporate practice of medicine regulations, and issues arising during the COVID-19 era and beyond. An active member of the American Telemedicine Association, Ms. de la Houssaye speaks and moderates sessions at its yearly fall forums and annual meetings.
Description
Under a management services agreement, a professional association employs physicians to provide telemedicine services and a management company handles the administrative, non-clinical aspects of those services. The management company may provide technology and other support that will facilitate telemedicine services. However, there are risks to operating under management services agreements.
Many states prohibit the corporate practice of medicine. This presents one of the challenges for management services arrangements, particularly if the entity has venture capital or private equity investments. Corporate practice of medicine laws prohibit an entity from providing medical services or employing physicians if non-physicians own it. Another risk is fee-splitting, which many states prohibit to reduce the likelihood that unnecessary medical services will be provided to maximize income.
A 2020 IRS private ruling held that a physician-owned medical services professional corporation could be included in a consolidated tax return filing and its management service organization and related corporations.
Listen as our authoritative panel of healthcare attorneys examines the nuts and bolts of structuring telemedicine management service agreements. The panel will explain considerations for management and healthcare providers, including the corporate practice of medicine, FMV, and fee-splitting. The panel will also discuss the IRS rule that addresses healthcare management services. The panel will outline guidance for counsel to address healthcare regulatory issues in telemedicine management services.
Outline
- Considerations when determining to enter into a management services arrangement
- Legal risks
- Corporate practice of medicine
- Fee-splitting
- Recent IRS ruling
- Regulatory issues
- Best practices
Benefits
The panel will review these and other key issues:
- What are the key considerations when determining whether to enter into a management services arrangement?
- What are the legal risks for counsel to consider when structuring management services agreements?
- What are the best practices for counsel to ensure regulatory compliance in a telemedicine management services agreement?
Related Courses

Healthcare AI Vendor Contracts: Customer and Vendor Negotiation Strategies, Risk Assessment, Key Provisions
Friday, April 25, 2025
1:00 p.m. ET./10:00 a.m. PT

Healthcare Providers and New Immigration Initiatives: Obligations to Patients and Employees, Compliance Strategies
Thursday, April 24, 2025
1:00 p.m. ET./10:00 a.m. PT

New CMS 60-Day Rule Revisions: Key Changes Impacting Reporting and Return of Medicare/Medicaid Overpayments
Saturday, March 22, 2025
1:00 p.m. ET./10:00 a.m. PT

The ACA and the New Administration: CMS Proposed Rule Impacting Marketplace Eligibility and Other Notable Actions
Tuesday, April 22, 2025
1:00 p.m. ET./10:00 a.m. PT
Recommended Resources
Navigating Modern Legal Challenges: A Comprehensive Guide
- Business & Professional Skills
- Career Advancement